Erin A. McClure

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
67 President St.
Phone843-792-7192
Email
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. McClure’s research interests and activities involve the study of relapse, withdrawal, craving, and treatment for nicotine and cannabis dependence through the use of outpatient, laboratory-based studies, as well as clinical trials assessing pharmacological and behavioral interventions in both adolescents and adults. Dr. McClure is also interested in the utilization of different technology outlets to conduct fine-grained analyses of the process of relapse to inform treatment efforts and deliver interventions in real-time.
    Collapse keywords
    smoking cessation, nicotine dependence, mobile health, relapse, pharmacotherapy, smoking, adolescent

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Smith TT, McClure EA, Halpern-Felsher B. Introduction to special issue of addictive behaviors: Tobacco regulatory science. Addict Behav. 2023 Jul; 142:107671. PMID: 36905899.
      Citations:    Fields:    Translation:HumansAnimals
    2. Walters KJ, Baker NL, Tomko RL, Gray KM, Carpenter MJ, McClure EA. Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial. BMC Psychol. 2023 Jan 25; 11(1):25. PMID: 36698194; PMCID: PMC9875760.
      Citations:    Fields:    Translation:HumansAnimalsCTClinical Trials
    3. McClure EA, Hamilton L, Schauer GL, Matson TE, Lapham GT. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addict Behav. 2023 05; 140:107621. PMID: 36706676.
      Citations:    Fields:    Translation:HumansAnimals
    4. Walters KJ, Gray KM, Gex KS, McClure EA. The role of emotion differentiation in the association between momentary affect and tobacco/nicotine craving in young adults. Nicotine Tob Res. 2023 Jan 05. PMID: 36610804.
      Citations:    Fields:    
    5. Gravely S, Driezen P, McClure EA, Hammond D, Michael Cummings K, Chan G, Hyland A, Borland R, East KA, Fong GT, Schauer GL, Quah ACK, Ouimet J, Smith DM. Corrigendum to "Differences between adults who smoke cigarettes daily and do and do not co-use cannabis: Findings from the 2020 ITC four country smoking and vaping survey" [Addict. Behav. 135 (2022) 107434]. Addict Behav. 2023 Feb; 137:107529. PMID: 36308840.
      Citations:    Fields:    
    6. Baker NL, Ramakrishnan V, Gray KM, Carpenter MJ, McClure EA, Tomko RL, Saladin ME, Baker NL, Ramakrishnan V, Gray KM, Carpenter MJ, McClure EA, Tomko RL, Saladin ME. Characterization of Salivary Progesterone in Female Smokers. Nicotine Tob Res. 2022 10 26; 24(11):1829-1833. PMID: 35533342; PMCID: PMC9596998.
      Citations: 1     Fields:    Translation:Humans
    7. Orr RK, Hoehn JL, Col NF, Goodwin RD, Shevorykin A, Carl E, Budney AJ, Rivard C, Wu M, McClure EA, Hyland A, Sheffer CE. Daily Cannabis Use Is a Barrier to Tobacco Cessation Among Tobacco Quitline Callers at 7-Month Follow-up. Nicotine Tob Res. 2022 10 17; 24(10):1684-1688. PMID: 35417562.
      Citations: 2     Fields:    Translation:HumansAnimals
    8. Gravely S, Driezen P, McClure EA, Hammond D, Michael Cummings K, Chan G, Hyland A, Borland R, East KA, Fong GT, Schauer GL, Quah ACK, Ouimet J, Smith DM. Differences between adults who smoke cigarettes daily and do and do not co-use cannabis: Findings from the 2020 ITC four country smoking and vaping survey. Addict Behav. 2022 Dec; 135:107434. PMID: 35908323.
      Citations: 1     Fields:    Translation:HumansAnimals
    9. Schick MR, Tomko RL, Maralit AM, Afzal Z, Squeglia LM, Freda A, Porrino L, Dahne J, McClure EA, Strain EC, Schick MR, Tomko RL, Maralit AM, Afzal Z, Squeglia LM, Freda A, Porrino L, Dahne J, McClure EA, Strain EC. Gender parity and homophily in the Drug and Alcohol Dependence editorial process. Drug Alcohol Depend. 2022 07 01; 236:109493. PMID: 35605531.
      Citations:    Fields:    Translation:Humans
    10. Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, Bradley KA, Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, Bradley KA. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Netw Open. 2022 05 02; 5(5):e2211677. PMID: 35604691; PMCID: PMC9127557.
      Citations: 4     Fields:    Translation:Humans
    11. Palmer AM, Tomko RL, Squeglia LM, Gray KM, Carpenter MJ, Smith TT, Dahne J, Toll BA, McClure EA, Palmer AM, Tomko RL, Squeglia LM, Gray KM, Carpenter MJ, Smith TT, Dahne J, Toll BA, McClure EA. A pilot feasibility study of a behavioral intervention for nicotine vaping cessation among young adults delivered via telehealth. Drug Alcohol Depend. 2022 03 01; 232:109311. PMID: 35123362; PMCID: PMC8885867.
      Citations:    
    12. McClure EA, Wahlquist AE, Tomko RL, Baker NL, Carpenter MJ, Bradley ED, Cato PA, Gipson CD, Gray KM, McClure EA, Wahlquist AE, Tomko RL, Baker NL, Carpenter MJ, Bradley ED, Cato PA, Gipson CD, Gray KM. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend. 2021 08 01; 225:108815. PMID: 34171822; PMCID: PMC8282766.
      Citations:    
    13. McClure EA, McClure EA. Accurate and sufficient measurement of cannabis and tobacco co-use: agreement, consensus and the path forward. Addiction. 2021 07; 116(7):1636-1637. PMID: 33855758; PMCID: PMC10042226.
      Citations:    
    14. Tuck BM, Karelitz JL, Tomko RL, Dahne J, Cato P, McClure EA, Tuck BM, Karelitz JL, Tomko RL, Dahne J, Cato P, McClure EA. Mobile, Remote, and Individual Focused: Comparing Breath Carbon Monoxide Readings and Abstinence Between Smartphone-Enabled and Stand-Alone Monitors. Nicotine Tob Res. 2021 03 19; 23(4):741-747. PMID: 33022057; PMCID: PMC7976935.
      Citations:    
    15. Karelitz JL, McClure EA, Wolford-Clevenger C, Pacek LR, Cropsey KL, Karelitz JL, McClure EA, Wolford-Clevenger C, Pacek LR, Cropsey KL. Cessation classification likelihood increases with higher expired-air carbon monoxide cutoffs: a meta-analysis. Drug Alcohol Depend. 2021 04 01; 221:108570. PMID: 33592559; PMCID: PMC8026538.
      Citations:    
    16. Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ, Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ. Remote Methods for Conducting Tobacco-Focused Clinical Trials. Nicotine Tob Res. 2020 12 12; 22(12):2134-2140. PMID: 32531046; PMCID: PMC7454765.
      Citations:    
    17. Hindocha C, McClure EA, Hindocha C, McClure EA. Unknown population-level harms of cannabis and tobacco co-use: if you don't measure it, you can't manage it. Addiction. 2021 07; 116(7):1622-1630. PMID: 33047862; PMCID: PMC8041912.
      Citations:    
    18. McClure EA, Rabin RA, Lee DC, Hindocha C, McClure EA, Rabin RA, Lee DC, Hindocha C. Treatment Implications Associated with Cannabis and Tobacco Co-Use. Curr Addict Rep. 2020 Dec; 7(4):533-544. PMID: 33777645; PMCID: PMC7992053.
      Citations:    
    19. McClure EA, Baker NL, Hood CO, Tomko RL, Squeglia LM, Flanagan JC, Carpenter MJ, Gray KM, McClure EA, Baker NL, Hood CO, Tomko RL, Squeglia LM, Flanagan JC, Carpenter MJ, Gray KM. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2020 07 16; 22(8):1374-1382. PMID: 31612956; PMCID: PMC7364825.
      Citations:    
    20. Hood CO, Tomko RL, Baker NL, Tuck BM, Flanagan JC, Carpenter MJ, Gray KM, Saladin ME, McClure EA, Hood CO, Tomko RL, Baker NL, Tuck BM, Flanagan JC, Carpenter MJ, Gray KM, Saladin ME, McClure EA. Examining sex, adverse childhood experiences, and oxytocin on neuroendocrine reactivity in smokers. Psychoneuroendocrinology. 2020 10; 120:104752. PMID: 32634745; PMCID: PMC7502468.
      Citations:    
    21. Baker NL, Gray KM, Ramakrishnan V, Tomko RL, McClure EA, Carpenter MJ, Saladin ME, Baker NL, Gray KM, Ramakrishnan V, Tomko RL, McClure EA, Carpenter MJ, Saladin ME. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addict Biol. 2021 03; 26(2):e12918. PMID: 32476209; PMCID: PMC7704566.
      Citations:    
    22. McClure EA, Carpenter MJ, McClure EA, Carpenter MJ. Commentary on Guillaumier et al. (2020): Is harm reduction a suitable outcome for historically hard-to-treat smokers? Addiction. 2020 07; 115(7):1356-1357. PMID: 32293762.
      Citations:    
    23. Flanagan JC, Leone RM, Gilmore AK, McClure EA, Gray KM, Flanagan JC, Leone RM, Gilmore AK, McClure EA, Gray KM. Association of Cannabis Use With Intimate Partner Violence Among Couples With Substance Misuse. Am J Addict. 2020 07; 29(4):323-330. PMID: 32219903; PMCID: PMC7305979.
      Citations:    
    24. Carpenter RW, Squeglia LM, Emery NN, McClure EA, Gray KM, Miranda R, Tomko RL, Carpenter RW, Squeglia LM, Emery NN, McClure EA, Gray KM, Miranda R, Tomko RL. Making pharmacotherapy trials for substance use disorder more efficient: Leveraging real-world data capture to maximize power and expedite the medication development pipeline. Drug Alcohol Depend. 2020 04 01; 209:107897. PMID: 32058245; PMCID: PMC7138753.
      Citations:    
    25. Tomko RL, Saladin ME, Baker NL, McClure EA, Carpenter MJ, Ramakrishnan VR, Heckman BW, Wray JM, Foster KT, Tiffany ST, Metts CL, Gray KM, Tomko RL, Saladin ME, Baker NL, McClure EA, Carpenter MJ, Ramakrishnan VR, Heckman BW, Wray JM, Foster KT, Tiffany ST, Metts CL, Gray KM. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88. PMID: 30371887; PMCID: PMC7297015.
      Citations:    
    26. McClure EA, Baker NL, Gray KM, Hood CO, Tomko RL, Carpenter MJ, Ramakrishnan VR, Buchanan CJ, Saladin ME, McClure EA, Baker NL, Gray KM, Hood CO, Tomko RL, Carpenter MJ, Ramakrishnan VR, Buchanan CJ, Saladin ME. The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm. Psychopharmacology (Berl). 2020 Feb; 237(2):543-555. PMID: 31792646; PMCID: PMC7024045.
      Citations:    
    27. Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ, Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019 12 01; 173(12):1146-1153. PMID: 31609433; PMCID: PMC6802269.
      Citations:    
    28. Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA, Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Curr Addict Rep. 2019 Dec; 6(4):429-436. PMID: 32133273; PMCID: PMC7055684.
      Citations:    
    29. Tomko RL, Baker NL, Hood CO, Gilmore AK, McClure EA, Squeglia LM, McRae-Clark AL, Sonne SC, Gray KM, Tomko RL, Baker NL, Hood CO, Gilmore AK, McClure EA, Squeglia LM, McRae-Clark AL, Sonne SC, Gray KM. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490. PMID: 31712969; PMCID: PMC7024037.
      Citations:    
    30. Tomko RL, McClure EA, Cato PA, Wang JB, Carpenter MJ, Karelitz JL, Froeliger B, Saladin ME, Gray KM, Tomko RL, McClure EA, Cato PA, Wang JB, Carpenter MJ, Karelitz JL, Froeliger B, Saladin ME, Gray KM. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052. PMID: 31415971; PMCID: PMC6708757.
      Citations:    
    31. Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM, Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 08; 29(7):559-572. PMID: 31009234; PMCID: PMC6727439.
      Citations:    
    32. Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM, Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111. PMID: 30901744; PMCID: PMC6467739.
      Citations:    
    33. Salazar CA, Tomko RL, Akbar SA, Squeglia LM, McClure EA, Salazar CA, Tomko RL, Akbar SA, Squeglia LM, McClure EA. Medical Cannabis Use among Adults in the Southeastern United States. Cannabis. 2019 Feb 09; 2(1):53-65. PMID: 30815638; PMCID: PMC6388700.
      Citations:    
    34. Goenaga J, Powell GL, Leyrer-Jackson JM, Piña J, Phan S, Prakapenka AV, Koebele SV, Namba MD, McClure EA, Bimonte-Nelson HA, Gipson CD, Goenaga J, Powell GL, Leyrer-Jackson JM, Pi?a J, Phan S, Prakapenka AV, Koebele SV, Namba MD, McClure EA, Bimonte-Nelson HA, Gipson CD. N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking. Addict Biol. 2020 01; 25(1):e12711. PMID: 30734439; PMCID: PMC6685767.
      Citations:    
    35. Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM, Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 12; 30:35-41. PMID: 30798020; PMCID: PMC6661207.
      Citations:    
    36. Powell GL, Leyrer-Jackson JM, Goenaga J, Namba MD, Piña J, Spencer S, Stankeviciute N, Schwartz D, Allen NP, Del Franco AP, McClure EA, Olive MF, Gipson CD, Powell GL, Leyrer-Jackson JM, Goenaga J, Namba MD, Pi?a J, Spencer S, Stankeviciute N, Schwartz D, Allen NP, Del Franco AP, McClure EA, Olive MF, Gipson CD. Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking. Physiol Rep. 2019 01; 7(1):e13958. PMID: 30632301; PMCID: PMC6328917.
      Citations:    
    37. McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, Carpenter MJ, Peters EN, McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, Carpenter MJ, Peters EN. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019 Jun; 27(3):265-275. PMID: 30556733; PMCID: PMC6538467.
      Citations:    
    38. Akbar SA, Tomko RL, Salazar CA, Squeglia LM, McClure EA, Akbar SA, Tomko RL, Salazar CA, Squeglia LM, McClure EA. Tobacco and cannabis co-use and interrelatedness among adults. Addict Behav. 2019 03; 90:354-361. PMID: 30522075; PMCID: PMC6342479.
      Citations:    
    39. Nowling TK, McClure E, Simpson A, Sheidow AJ, Shaw D, Feghali-Bostwick C, Nowling TK, McClure E, Simpson A, Sheidow AJ, Shaw D, Feghali-Bostwick C. A Focused Career Development Program for Women Faculty at an Academic Medical Center. J Womens Health (Larchmt). 2018 12; 27(12):1474-1481. PMID: 30251910.
      Citations:    
    40. McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM, McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66. PMID: 30218864; PMCID: PMC6200636.
      Citations:    
    41. McClure EA, Tomko RL, Carpenter MJ, Treiber FA, Gray KM, McClure EA, Tomko RL, Carpenter MJ, Treiber FA, Gray KM. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570. PMID: 29737885; PMCID: PMC6059983.
      Citations:    
    42. Acquavita SP, Krummel DA, Talks A, Cobb A, McClure E, Acquavita SP, Krummel DA, Talks A, Cobb A, McClure E. Assessing the Digital Divide Among Low-Income Perinatal Women: Opportunities for Provision of Health Information and Counseling. Telemed J E Health. 2019 01; 25(1):48-54. PMID: 29708865; PMCID: PMC6913108.
      Citations:    
    43. Tomko RL, McClure EA, Tomko RL, McClure EA. Introduction to the special issue: Utilizing ambulatory assessment to better understand the etiology, maintenance, treatment, and remission of addictive disorders. Addict Behav. 2018 08; 83:1-4. PMID: 29661656.
      Citations:    
    44. Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA, Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse. 2019; 45(1):26-41. PMID: 29513609; PMCID: PMC6128791.
      Citations:    
    45. Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM, Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22. PMID: 29413434; PMCID: PMC5889716.
      Citations:    
    46. Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM, Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7. PMID: 29112827; PMCID: PMC5742553.
      Citations:    
    47. Buchanan C, Nahhas GJ, Guille C, Cummings KM, Wheeler C, McClure EA, Buchanan C, Nahhas GJ, Guille C, Cummings KM, Wheeler C, McClure EA. Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program. Matern Child Health J. 2017 Sep; 21(9):1790-1797. PMID: 28702864; PMCID: PMC5693712.
      Citations:    
    48. Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM, Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58. PMID: 28847455; PMCID: PMC5607644.
      Citations:    
    49. Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR, Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257. PMID: 28623823; PMCID: PMC5535813.
      Citations:    
    50. McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM, McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20. PMID: 28511033; PMCID: PMC5587128.
      Citations:    
    51. Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM, Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435. PMID: 27838746; PMCID: PMC5228531.
      Citations:    
    52. W Adams Z, McClure EA, Gray KM, Danielson CK, Treiber FA, Ruggiero KJ, W Adams Z, McClure EA, Gray KM, Danielson CK, Treiber FA, Ruggiero KJ. Mobile devices for the remote acquisition of physiological and behavioral biomarkers in psychiatric clinical research. J Psychiatr Res. 2017 02; 85:1-14. PMID: 27814455; PMCID: PMC5191962.
      Citations:    
    53. Lévesque A, Campbell AN, Pavlicova M, Hu MC, Walker R, McClure EA, Ghitza UE, Bailey G, Stitzer M, Nunes EV, L?vesque A, Campbell AN, Pavlicova M, Hu MC, Walker R, McClure EA, Ghitza UE, Bailey G, Stitzer M, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addict Behav. 2017 02; 65:74-80. PMID: 27776269; PMCID: PMC5483182.
      Citations:    
    54. Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM, Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016 12; 63:172-7. PMID: 27521979; PMCID: PMC4993655.
      Citations:    
    55. Flanagan JC, Hakes JK, McClure EA, Snead AL, Back SE, Flanagan JC, Hakes JK, McClure EA, Snead AL, Back SE. Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. Am J Addict. 2016 06; 25(4):283-90. PMID: 27196699; PMCID: PMC4934605.
      Citations:    
    56. Foster KT, Li N, McClure EA, Sonne SC, Gray KM, Foster KT, Li N, McClure EA, Sonne SC, Gray KM. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22. PMID: 27211992; PMCID: PMC4909476.
      Citations:    
    57. McClure E, Baker N, Carpenter MJ, Treiber FA, Gray K, McClure E, Baker N, Carpenter MJ, Treiber FA, Gray K. Attitudes and interest in technology-based treatment and the remote monitoring of smoking among adolescents and emerging adults. J Smok Cessat. 2017 Jun; 12(2):88-98. PMID: 28580019; PMCID: PMC5453644.
      Citations:    
    58. Froeliger B, McConnell PA, Stankeviciute N, McClure EA, Kalivas PW, Gray KM, Froeliger B, McConnell PA, Stankeviciute N, McClure EA, Kalivas PW, Gray KM. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242. PMID: 26454838; PMCID: PMC4633320.
      Citations:    
    59. Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, Gray KM, Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, Gray KM. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406. PMID: 25762749; PMCID: PMC4432400.
      Citations:    
    60. Wray JM, Gray KM, McClure EA, Carpenter MJ, Tiffany ST, Saladin ME, Wray JM, Gray KM, McClure EA, Carpenter MJ, Tiffany ST, Saladin ME. Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res. 2015 Apr; 17(4):438-42. PMID: 25762753; PMCID: PMC4432398.
      Citations:    
    61. Gray KM, McClure EA, Baker NL, Hartwell KJ, Carpenter MJ, Saladin ME, Gray KM, McClure EA, Baker NL, Hartwell KJ, Carpenter MJ, Saladin ME. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34. PMID: 25727442; PMCID: PMC4430389.
      Citations:    
    62. Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML, Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML. The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study. Subst Abus. 2015; 36(4):420-6. PMID: 25671593; PMCID: PMC4532645.
      Citations:    
    63. McClure EA, Lydiard JB, Goddard SD, Gray KM, McClure EA, Lydiard JB, Goddard SD, Gray KM. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2015 Jan; 24(1):47-52. PMID: 25823635; PMCID: PMC4389632.
      Citations:    
    64. McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV, McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat. 2015 Jun; 53:39-46. PMID: 25595301; PMCID: PMC4414703.
      Citations:    
    65. McClure EA, Lydiard JB, Goddard SD, Gray KM. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2014 Nov 6. PMID: 25376891.
      Citations:    
    66. Saladin ME, Wray JM, Carpenter MJ, McClure EA, LaRowe SD, Upadhyaya HP, Gray KM, Saladin ME, Wray JM, Carpenter MJ, McClure EA, LaRowe SD, Upadhyaya HP, Gray KM. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11. PMID: 25324432; PMCID: PMC4402356.
      Citations:    
    67. McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM, McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23. PMID: 25179587; PMCID: PMC4252394.
      Citations:    
    68. McClure EA, Baker NL, Gipson CD, Carpenter MJ, Roper AP, Froeliger BE, Kalivas PW, Gray KM, McClure EA, Baker NL, Gipson CD, Carpenter MJ, Roper AP, Froeliger BE, Kalivas PW, Gray KM. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6. PMID: 25062287; PMCID: PMC4262740.
      Citations:    
    69. Acquavita SP, McClure EA, Hargraves D, Stitzer M, Acquavita SP, McClure EA, Hargraves D, Stitzer M. Environmental tobacco smoke exposure among smokers and non-smokers receiving outpatient substance abuse treatment. Addict Behav. 2014 Dec; 39(12):1718-22. PMID: 25117848; PMCID: PMC4182101.
      Citations:    
    70. Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE, Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry. 2014 Jun; 171(6):683-90. PMID: 24700332; PMCID: PMC4079279.
      Citations:    
    71. McClure EA, Baker NL, Gray KM, McClure EA, Baker NL, Gray KM. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am J Drug Alcohol Abuse. 2014 Jul; 40(4):285-91. PMID: 24720376; PMCID: PMC4118750.
      Citations:    
    72. Raiff BR, Karatas Ç, McClure EA, Pompili D, Walls TA, Raiff BR, Karatas ?, McClure EA, Pompili D, Walls TA. Laboratory Validation of Inertial Body Sensors to Detect Cigarette Smoking Arm Movements. Electronics (Basel). 2014 Feb 27; 3(1):87-110. PMID: 25553255; PMCID: PMC4278663.
      Citations:    
    73. McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM, McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106. PMID: 24442756; PMCID: PMC4009342.
      Citations:    
    74. Carpenter MJ, Saladin ME, Larowe SD, McClure EA, Simonian S, Upadhyaya HP, Gray KM, Carpenter MJ, Saladin ME, Larowe SD, McClure EA, Simonian S, Upadhyaya HP, Gray KM. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15. PMID: 24042699; PMCID: PMC3880235.
      Citations:    
    75. Campbell AN, Nunes EV, McClure EA, Hu MC, Turrigiano E, Goldman B, Stabile PQ, Campbell AN, Nunes EV, McClure EA, Hu MC, Turrigiano E, Goldman B, Stabile PQ. Characteristics of an outpatient treatment sample by primary substance of abuse. J Addict Med. 2013 Sep-Oct; 7(5):363-71. PMID: 24089040; PMCID: PMC3790139.
      Citations:    
    76. McClure EA, Acquavita SP, Dunn KE, Stoller KB, Stitzer ML, McClure EA, Acquavita SP, Dunn KE, Stoller KB, Stitzer ML. Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. J Subst Abuse Treat. 2014 Feb; 46(2):194-201. PMID: 23988192; PMCID: PMC3840070.
      Citations:    
    77. McClure EA, Saladin ME, Baker NL, Carpenter MJ, Gray KM, McClure EA, Saladin ME, Baker NL, Carpenter MJ, Gray KM. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6. PMID: 24018226; PMCID: PMC3805754.
      Citations:    
    78. McClure EA, Gray KM, McClure EA, Gray KM. The Remote Monitoring of Smoking in Adolescents. Adolesc Psychiatry (Hilversum). 2013 Apr 01; 3(2):156-162. PMID: 24834379; PMCID: PMC4019076.
      Citations:    
    79. McClure EA, Acquavita SP, Harding E, Stitzer ML, McClure EA, Acquavita SP, Harding E, Stitzer ML. Utilization of communication technology by patients enrolled in substance abuse treatment. Drug Alcohol Depend. 2013 Apr 01; 129(1-2):145-50. PMID: 23107600; PMCID: PMC3568219.
      Citations:    
    80. McClure EA, Vandrey RG, Johnson MW, Stitzer ML, McClure EA, Vandrey RG, Johnson MW, Stitzer ML. Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res. 2013 Jan; 15(1):139-48. PMID: 22573730; PMCID: PMC3524062.
      Citations:    
    81. Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR, Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials. 2012 Mar; 33(2):386-95. PMID: 22085803; PMCID: PMC3268951.
      Citations:    
    82. Orr RK, Hoehn JL, Col NF, McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology (Berl). 2012 Mar; 220(2):309-18. PMID: 21922170; PMCID: PMC3641906.
      Citations:    
    83. McClure EA, Saulsgiver KA, Wynne CD, McClure EA, Saulsgiver KA, Wynne CD. D-amphetamine, nicotine, and haloperidol produce similar disruptions in spatial and nonspatial temporal discrimination procedures. Behav Pharmacol. 2011 Apr; 22(2):101-12. PMID: 21301325; PMCID: PMC3366435.
      Citations:    
    84. McClure EA, Saulsgiver KA, Wynne CD, McClure EA, Saulsgiver KA, Wynne CD. Disruptive effects of stimulus intensity on two variations of a temporal discrimination procedure. J Exp Anal Behav. 2010 Jul; 94(1):57-68. PMID: 21279162; PMCID: PMC2893617.
      Citations:    
    85. McClure EA, Saulsgiver KA, Wynne CD, McClure EA, Saulsgiver KA, Wynne CD. ABA chronic dosing of D-amphetamine produces differential drug effects in two variants of a temporal discrimination procedure in pigeons. Behav Pharmacol. 2009 Dec; 20(8):705-19. PMID: 19901824.
      Citations:    
    86. McClure EA, Saulsgiver KA, Wynne CD, McClure EA, Saulsgiver KA, Wynne CD. Effects of acute and chronic d-amphetamine on two variations of a temporal discrimination procedure. Behav Pharmacol. 2009 Oct; 20(7):668-72. PMID: 19738462.
      Citations:    
    87. McClure EA, Saulsgiver KA, Wynne CD, McClure EA, Saulsgiver KA, Wynne CD. Manipulating pre-feed, density of reinforcement, and extinction produces disruption in the Location variation of a temporal discrimination task in pigeons. Behav Processes. 2009 Sep; 82(1):85-9. PMID: 19615617.
      Citations:    
    88. Saulsgiver KA, McClure EA, Wynne CD, Saulsgiver KA, McClure EA, Wynne CD. Effects of amphetamine on differential reinforcement of low rates of responding. Behav Pharmacol. 2007 Mar; 18(2):119-33. PMID: 17351419.
      Citations:    
    89. Jazbec S, Hardin MG, Schroth E, McClure E, Pine DS, Ernst M, Jazbec S, Hardin MG, Schroth E, McClure E, Pine DS, Ernst M. Age-related influence of contingencies on a saccade task. Exp Brain Res. 2006 Oct; 174(4):754-62. PMID: 16733706; PMCID: PMC2733163.
      Citations:    
    90. Saulsgiver KA, McClure EA, Wynne CD, Saulsgiver KA, McClure EA, Wynne CD. Effects of d-amphetamine on the behavior of pigeons exposed to the peak procedure. Behav Processes. 2006 Feb 28; 71(2-3):268-85. PMID: 16413140.
      Citations:    
    91. Jazbec S, McClure E, Hardin M, Pine DS, Ernst M, Jazbec S, McClure E, Hardin M, Pine DS, Ernst M. Cognitive control under contingencies in anxious and depressed adolescents: an antisaccade task. Biol Psychiatry. 2005 Oct 15; 58(8):632-9. PMID: 16018983.
      Citations:    
    92. McClure EA, Saulsgiver KA, Wynne CD, McClure EA, Saulsgiver KA, Wynne CD. Effects of D-amphetamine on temporal discrimination in pigeons. Behav Pharmacol. 2005 Jul; 16(4):193-208. PMID: 15961959.
      Citations:    
    McClure's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (263)
    Explore
    _
    Co-Authors (35)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _